#United States #FDA Clearance #ManaMed #Denton, Texas #PlasmaFlow

ManaMed's Groundbreaking PlasmaFlow® X: A New Era in Recovery

ManaMed LLC has recently announced that its latest device, the PlasmaFlow® X, has received FDA 510(k) clearance, marking a significant advancement in the field of sequential compression therapy. This tubeless system not only provides enhanced therapy but does so in a sleek, compact design that sets a new standard for patient care and convenience.

A Compact, Innovative Design

The PlasmaFlow® X is a notable upgrade from its predecessor, boasting over a 30% reduction in size while doubling the battery life. This makes it ideal for both professional medical settings and home use. The device is designed to maximize efficiency, both by saving space in surgical centers and by reducing packaging waste, which is increasingly important in today's environmentally-conscious market.

Equipped with a modern USB-C charging interface and a clear, expanded LCD display, the PlasmaFlow® X seamlessly integrates into everyday usage. Users can easily check vital information such as battery status, pressure levels, and patient adherence, all contributing to a more intuitive experience for healthcare providers and patients alike.

An Important Tool for DVT Prevention

The PlasmaFlow® X is classified as a Class II device specifically indicated for aiding in the prevention of Deep Vein Thrombosis (DVT). It supports patients who are at risk of developing DVT due to long periods of immobility. Moreover, it helps in reducing post-operative pain and swelling while enhancing blood circulation, making it an essential device for recovery both in clinical settings and at home.

Trevor Theriot, President and CEO of ManaMed, shared his excitement about the launch, stating, "PlasmaFlow X is a generational leap for sequential compression. In a category long defined by incremental updates, our team has re-imagined every detail—from its compact design to the all-day battery and state-of-the-art display—to deliver industry-leading therapy in a remarkably portable system. This is our most exciting product launch in ManaMed's 10-year history, reflecting our commitment to innovation that benefits patients and clinicians."

Market Availability

The PlasmaFlow® X is now approved for marketing in the United States. Healthcare facilities and providers interested in incorporating this new technology can obtain it through ManaMed and authorized distributors. For more information on ordering and specifications, visit ManaMed.com or reach out via email at [email protected].

About ManaMed

ManaMed is at the forefront of innovation in the orthopedic solutions market. Focused on keeping active individuals on track following injury or surgery, the company offers a diverse range of products, including vascular therapies, DVT prevention equipment, and more. By partnering with professionals across various medical sectors, ManaMed ensures that patients of all backgrounds receive the best possible care during their recovery processes.

As ManaMed celebrates a decade of innovation and excellence, the introduction of PlasmaFlow® X reaffirms its commitment to creating high-quality, effective solutions for improved rehabilitation and recovery. As this groundbreaking device hits the market, the potential benefits for countless patients are substantial, promising improved comfort and recovery outcomes for those in need.

For further inquiries, please contact Julie Roberts at [email protected] or call 1.888.508.0712.